↓ Skip to main content

Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series

Overview of attention for article published in Cardio-Oncology, March 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series
Published in
Cardio-Oncology, March 2021
DOI 10.1186/s40959-021-00095-x
Pubmed ID
Authors

Robert S. Zhang, Allison Padegimas, Kathleen M. Murphy, Peter T. Evans, Carli J. Peters, Christopher M. Domenico, Mahesh K. Vidula, Paul J. Mather, Marisa Cevasco, Roger B. Cohen, Joseph R. Carver, Rupal P. O’Quinn

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 31 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 7 23%
Researcher 4 13%
Student > Master 3 10%
Other 2 6%
Student > Bachelor 1 3%
Other 3 10%
Unknown 11 35%
Readers by discipline Count As %
Medicine and Dentistry 8 26%
Unspecified 7 23%
Agricultural and Biological Sciences 1 3%
Nursing and Health Professions 1 3%
Psychology 1 3%
Other 1 3%
Unknown 12 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 September 2021.
All research outputs
#13,222,153
of 23,301,510 outputs
Outputs from Cardio-Oncology
#71
of 127 outputs
Outputs of similar age
#191,579
of 431,290 outputs
Outputs of similar age from Cardio-Oncology
#6
of 11 outputs
Altmetric has tracked 23,301,510 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 127 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,290 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.